Second Diagnostic Opinions in Sarcoma Linked to Improved Survival Outcomes Phase 2 trial results show anlotinib with anthracyclines and ifosfamide yields a 30.8% ORR and an 82.7% DCR in advanced soft ...

Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive ...

Causes of Soft Tissue Sarcoma:The exact soft tissue sarcoma causes remain unclear, but several risk factors have been identified. These include a family history of inherited conditions such as ...

Soft tissue sarcomas are rare solid tumors that are being increasingly classified and treated by subtype. Approximately 12,020 people will be diagnosed with a soft tissue sarcoma in the United States ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...

A doctor may use an ultrasound scan as one of the first tests to diagnose and assess a soft tissue sarcoma. An ultrasound can help doctors determine the nature of the lump and plan the most effective ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

This distinction suggests that the underlying biology of sarcomas may differ from that of more common cancers. There are many subtypes of the cancer, which develops in soft tissues such as fat, blood ...

One expert from the University of Colorado Cancer Center explains the multidisciplinary aspect of sarcoma care to maximize patients’ functioning. Treating patients with soft tissue sarcoma or bone ...

Lumps and bumps are common in childhood, but when they form in soft tissue without an obvious cause, they could be pediatric soft tissue sarcoma (STS). In children, cancer that forms in the soft ...